CRISPR Therapeutics AG (CRSP)
52.61
-0.90
(-1.68%)
USD |
NASDAQ |
Jan 20, 16:00
52.46
-0.15
(-0.29%)
After-Hours: 06:57
CRISPR Therapeutics Market Cap: 5.014B for Jan. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vertex Pharmaceuticals, Inc. | 112.16B |
| Intellia Therapeutics, Inc. | 1.486B |
| Beam Therapeutics, Inc. | 3.142B |
| Novartis AG | 275.50B |
| BeOne Medicines Ltd. | 36.99B |
Market Cap Related Metrics
| PS Ratio | 120.00 |
| PEG Ratio | -0.0966 |
| Price to Book Value | 2.617 |
| Price | 52.61 |
| Earnings Yield | -10.61% |
| PEGY Ratio | -0.0966 |